Drug Substances : Navigating Regulatory Requirements

With a central focus on human safety, high quality standards for drug products are upheld worldwide through various drug agencies. In order to ensure that drug products intended for human use fulfil the safety needs of patients, regulatory approval...

Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia A and PKU

Generation Bio announced the closing of a $110 million Series C financing. Proceeds will be used to advance the company's two lead liver-targeted programs for hemophilia A and phenylketonuria into IND-enabling studies and clinical development.

Boehringer Ingelheim Partners with Enleofen to Develop Anti Therapies for Fibrotic Diseases

Boehringer Ingelheim and Enleofen announced the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin platform by Boehringer...

Eli Lilly Collaboration with Strateos Launch Remote-Controlled Robotic Cloud Lab

Eli Lilly and Strateos unveiled a new robotic laboratory in San Diego, California designed to accelerate the drug discovery process. The Lilly Life Sciences Studio lab...

Mundipharma enters partnership with Samsung Bioepis to expand bio-similars into Hong Kong and Taiwan

Mundipharma partnership with Samsung Bioepis to commercialize Samsung Bioepis first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ biosimilar candidates...

Bayer and Exscientia collaborate to leverage the potential of AI in oncology and drug discovery

BBayer and Exscientia have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia's proprietary...

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

STA Pharmaceutical announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China.